Sponsored Projects Administration

The world’s cancer immunotherapy market on path to reach 9 billion USD by 2022

Published July 18, 2014 by OSP


The market for cancer immunotherapy is set to grow from a value of $1.1 billion in 2012 to nearly $9 billion in 2022, driven by the expected market entry of nine novel immunotherapies in new oncology indications and/or patient populations.

Read More